Heads up, Spago Nanomedical shareholders! A nomination committee has been assembled, and its work is crucial for the company's future. This committee is responsible for preparing proposals for the Annual General Meeting (AGM) in 2026. But what exactly does this mean for you? Let's dive in.
Following the guidelines set by the previous AGM, Spago Nanomedical has appointed a nomination committee. This committee's primary role is to suggest key decisions for the upcoming AGM.
The committee's formation is based on the largest shareholders as of September 30, 2025, who expressed their interest in participating. This ensures that the committee represents a significant portion of the company's ownership.
Here's who's on the committee, representing approximately 60% of all Spago Nanomedical shares:
- Peter Lindell, representing Cidro Förvaltning AB and his own holdings, will chair the Nomination Committee.
- Mikael Lönn, representing his own holdings.
- Eva Redhe, representing her own holdings.
So, what will this committee actually do? They'll be putting forth recommendations for:
- The chairman of the AGM.
- The election of the chairman and other members of the board of directors.
- The compensation for each board member.
- The election and compensation of auditors.
Important for shareholders: If you have any proposals you'd like the nomination committee to consider, you're encouraged to submit them. Send your ideas via e-mail to [email protected] no later than January 31, 2026.
For any further questions, you can reach out to Mats Hansen, CEO of Spago Nanomedical AB, at +46 46 811 88 or [email protected]
A bit about Spago Nanomedical: This Swedish company is in the clinical development phase, focusing on innovative treatments for cancer and other serious diseases. They utilize a unique platform of polymeric materials. Their shares are listed on Nasdaq First North Growth Market under the ticker SPAGO. For more details, visit their website. FNCA Sweden AB serves as the company's Certified Adviser.
Now, here's a thought-provoking question: Do you believe the composition of this nomination committee effectively represents the interests of all shareholders? Share your thoughts in the comments below! What other factors do you think are important when selecting a nomination committee?
